Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −12 vs. previous quarter
- 16
- 13F valueReported value at the end of Q2 2026
- $641.0K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding LNAI, Q2 2026
No superinvestor reported holding LNAI at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Lunai Bioworks Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 24, 2024 (view filing) | Jul 29 | 87 daysLate | William Anderson Wittekind10% Owner | SSale | −1.11K | $1.30 | −$1.45K | −0.1%840.3K after | |
| Jul 19, 2024 (view filing) | Jul 17 | 2 days | William Anderson Wittekind10% Owner | SSale | −16.4K | $1.46 | −$23.9K | −1.9%841.4K after | |
| Jul 8, 2024 (view filing) | Jul 3-5 | 5 days | William Anderson Wittekind10% Owner | SSale | −110.0K | $1.53 | −$168.5K | −10.1%974.3K after | 2 lots |
| Jul 3, 2024 (view filing) | Jul 1-2 | 2 days | William Anderson Wittekind10% Owner | SSale | −94.6K | $1.55 | −$146.8K | −8.0%1.08M after | 2 lots |
| Jun 27, 2024 (view filing) | Jun 25-27 | 2 days | William Anderson Wittekind10% Owner | SSale | −84.7K | $1.56 | −$132.1K | −6.7%1.18M after | 3 lots |
| Jun 18, 2024 (view filing) | Jun 14 | 4 days | William Anderson Wittekind10% Owner | SSale | −50.0K | $1.58 | −$79.0K | −3.8%1.26M after | |
| May 20, 2022 (view filing) | May 18 | 2 days | Gumrukcu Serhat10% Owner | SSale | −253.5K | $8.00 | −$2.03M | −2.0%12.3M after | 2 lots |
| May 20, 2022 (view filing) | May 18 | 2 days | Sindlev ReneDirector, 10% Owner | PPurchase | +253.5K | $8.00 | +$2.03M | New position128.5K after | 2 lots |
| Mar 24, 2022 (view filing) | Mar 22 | 2 days | Sandler Carl Forest JrDirector, 10% Owner | SSale | −1.93K | $9.06 | −$17.5K | −0.1%3.19M after | |
| Feb 23, 2022 (view filing) | Feb 18-23 | 5 days | Sandler Carl Forest JrDirector, 10% Owner | SSale | −6.80K | $9.03 | −$61.4K | −0.2%3.19M after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Lunai Bioworks Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ground Swell Capital, LLC | 53,211 | $174.0K | 0.19% | +53,211 | New |
| State Street Corp | 37,537 | $122.7K | 0.00% | +1,809+5.1% | Added |
| Geode Capital Management, LLC | 24,156 | $79.0K | 0.00% | −158,081−86.7% | Reduced |
| Jane Street Group, LLC | 23,683 | $77.4K | 0.00% | +23,683 | New |
| Vanguard Capital Management LLC | 16,081 | $52.6K | 0.00% | −80,418−83.3% | Reduced |
| BlackRock, Inc. | 15,906 | $52.0K | 0.00% | −111,408−87.5% | Reduced |
| Virtu Financial LLC | 12,863 | $42.0K | 0.00% | −62,312−82.9% | Reduced |
| Vanguard Fiduciary Trust Co | 8,642 | $28.3K | 0.00% | −60,494−87.5% | Reduced |
| Royal Bank of Canada | 1,687 | $5.00K | 0.00% | +1,361+417.5% | Added |
| Tower Research Capital LLC (TRC) | 1,405 | $4.59K | 0.00% | −3,298−70.1% | Reduced |